アルブミン(賦形剤)の世界市場2021-2026:ヒト血清アルブミン、組換えアルブミン

LP Informationが発行した調査報告書(LPI21JL16396)
◆英語タイトル:Global Albumin (as Excipient) Market Growth 2021-2026
◆商品コード:LPI21JL16396
◆発行会社(リサーチ会社):LP Information
◆発行日:2021年7月(※2024年版があります。お問い合わせください。)
◆ページ数:163
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

LP Information社の「アルブミン(賦形剤)の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ヒト血清アルブミン、組換えアルブミンなど、用途別には、細胞培養培地、医療サプリメント、治療薬などにセグメント区分してまとめました。アルブミン(賦形剤)のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・アルブミン(賦形剤)の世界市場概要(サマリー)
・アルブミン(賦形剤)の企業別販売量・売上
・アルブミン(賦形剤)の企業別市場シェア
・アルブミン(賦形剤)の世界市場規模 2016年-2021年:種類別(ヒト血清アルブミン、組換えアルブミン)
・アルブミン(賦形剤)の世界市場規模 2016年-2021年:用途別(細胞培養培地、医療サプリメント、治療薬)
・アルブミン(賦形剤)の南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・アルブミン(賦形剤)のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・アルブミン(賦形剤)のヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・アルブミン(賦形剤)の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・アルブミン(賦形剤)市場の成長要因・課題・動向
・アルブミン(賦形剤)の世界市場予測 2021年-2026年
・アルブミン(賦形剤)の南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・アルブミン(賦形剤)のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・アルブミン(賦形剤)のヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・アルブミン(賦形剤)の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・アルブミン(賦形剤)の世界市場予測:種類別(ヒト血清アルブミン、組換えアルブミン)
・アルブミン(賦形剤)の世界市場予測:用途別(細胞培養培地、医療サプリメント、治療薬)
・主要企業分析
【レポートの概要】

According to this latest study, the 2021 growth of Albumin (as Excipient) will have significant change from previous year. By the most conservative estimates of global Albumin (as Excipient) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 4006.4 million in 2020. Over the next five years the Albumin (as Excipient) market will register a 6.3% CAGR in terms of revenue, the global market size will reach US$ 5120.9 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Albumin (as Excipient) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Human Serum Albumin
Recombinant Albumin
In terms of type, Human Serum Albumin has the highest proportion of revenue, exceeding 98% in 2019.

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Cell Culture Media
Medical Supplements
Therapeutics
Therapeutics had the highest share of sales by application, at 73.27% in 2019.

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
CSL
Grifols
Takeda
Octapharma
Hualan Bio
CBPO
Shanghai RAAS
Kedrion
LFB Group
Albumedix
Biotest
Merck
Ventria (InVitria)
HiMedia

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Albumin (as Excipient) Consumption 2016-2026
2.1.2 Albumin (as Excipient) Consumption CAGR by Region
2.2 Albumin (as Excipient) Segment by Type
2.2.1 Human Serum Albumin
2.2.2 Recombinant Albumin
2.3 Albumin (as Excipient) Sales by Type
2.3.1 Global Albumin (as Excipient) Sales Market Share by Type (2016-2021)
2.3.2 Global Albumin (as Excipient) Revenue and Market Share by Type (2016-2021)
2.3.3 Global Albumin (as Excipient) Sale Price by Type (2016-2021)
2.4 Albumin (as Excipient) Segment by Application
2.4.1 Cell Culture Media
2.4.2 Medical Supplements
2.4.3 Therapeutics
2.5 Albumin (as Excipient) Sales by Application
2.5.1 Global Albumin (as Excipient) Sale Market Share by Application (2016-2021)
2.5.2 Global Albumin (as Excipient) Revenue and Market Share by Application (2016-2021)
2.5.3 Global Albumin (as Excipient) Sale Price by Application (2016-2021)

3 Global Albumin (as Excipient) by Company
3.1 Global Albumin (as Excipient) Sales Market Share by Company
3.1.1 Global Albumin (as Excipient) Sales by Company (2019-2021)
3.1.2 Global Albumin (as Excipient) Sales Market Share by Company (2019-2021)
3.2 Global Albumin (as Excipient) Revenue Market Share by Company
3.2.1 Global Albumin (as Excipient) Revenue by Company (2019-2021)
3.2.2 Global Albumin (as Excipient) Revenue Market Share by Company (2019-2021)
3.3 Global Albumin (as Excipient) Sale Price by Company
3.4 Global Manufacturers Albumin (as Excipient) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Albumin (as Excipient) Product Location Distribution
3.4.2 Players Albumin (as Excipient) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Albumin (as Excipient) by Region
4.1 Global Albumin (as Excipient) by Region
4.1.1 Global Albumin (as Excipient) Sales by Region
4.1.2 Global Albumin (as Excipient) Revenue by Region
4.2 Americas Albumin (as Excipient) Sales Growth
4.3 APAC Albumin (as Excipient) Sales Growth
4.4 Europe Albumin (as Excipient) Sales Growth
4.5 Middle East & Africa Albumin (as Excipient) Sales Growth

5 Americas
5.1 Americas Albumin (as Excipient) Sales by Country
5.1.1 Americas Albumin (as Excipient) Sales by Country (2016-2021)
5.1.2 Americas Albumin (as Excipient) Revenue by Country (2016-2021)
5.2 Americas Albumin (as Excipient) Sales by Type
5.3 Americas Albumin (as Excipient) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Albumin (as Excipient) Sales by Region
6.1.1 APAC Albumin (as Excipient) Sales by Region (2016-2021)
6.1.2 APAC Albumin (as Excipient) Revenue by Region (2016-2021)
6.2 APAC Albumin (as Excipient) Sales by Type
6.3 APAC Albumin (as Excipient) Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Albumin (as Excipient) by Country
7.1.1 Europe Albumin (as Excipient) Sales by Country (2016-2021)
7.1.2 Europe Albumin (as Excipient) Revenue by Country (2016-2021)
7.2 Europe Albumin (as Excipient) Sales by Type
7.3 Europe Albumin (as Excipient) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Albumin (as Excipient) by Country
8.1.1 Middle East & Africa Albumin (as Excipient) Sales by Country (2016-2021)
8.1.2 Middle East & Africa Albumin (as Excipient) Revenue by Country (2016-2021)
8.2 Middle East & Africa Albumin (as Excipient) Sales by Type
8.3 Middle East & Africa Albumin (as Excipient) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Albumin (as Excipient) Distributors
10.3 Albumin (as Excipient) Customer

11 Global Albumin (as Excipient) Market Forecast
11.1 Global Albumin (as Excipient) Forecast by Region
11.1.1 Global Albumin (as Excipient) Forecast by Regions (2021-2026)
11.2.2 Global Albumin (as Excipient) Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Albumin (as Excipient) Forecast by Type
11.7 Global Albumin (as Excipient) Forecast by Application

12 Key Players Analysis
12.1 CSL
12.1.1 CSL Company Information
12.1.2 CSL Albumin (as Excipient) Product Offered
12.1.3 CSL Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 CSL Main Business Overview
12.1.5 CSL Latest Developments
12.2 Grifols
12.2.1 Grifols Company Information
12.2.2 Grifols Albumin (as Excipient) Product Offered
12.2.3 Grifols Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Grifols Main Business Overview
12.2.5 Grifols Latest Developments
12.3 Takeda
12.3.1 Takeda Company Information
12.3.2 Takeda Albumin (as Excipient) Product Offered
12.3.3 Takeda Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Takeda Main Business Overview
12.3.5 Takeda Latest Developments
12.4 Octapharma
12.4.1 Octapharma Company Information
12.4.2 Octapharma Albumin (as Excipient) Product Offered
12.4.3 Octapharma Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Octapharma Main Business Overview
12.4.5 Octapharma Latest Developments
12.5 Hualan Bio
12.5.1 Hualan Bio Company Information
12.5.2 Hualan Bio Albumin (as Excipient) Product Offered
12.5.3 Hualan Bio Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Hualan Bio Main Business Overview
12.5.5 Hualan Bio Latest Developments
12.6 CBPO
12.6.1 CBPO Company Information
12.6.2 CBPO Albumin (as Excipient) Product Offered
12.6.3 CBPO Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 CBPO Main Business Overview
12.6.5 CBPO Latest Developments
12.7 Shanghai RAAS
12.7.1 Shanghai RAAS Company Information
12.7.2 Shanghai RAAS Albumin (as Excipient) Product Offered
12.7.3 Shanghai RAAS Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Shanghai RAAS Main Business Overview
12.7.5 Shanghai RAAS Latest Developments
12.8 Kedrion
12.8.1 Kedrion Company Information
12.8.2 Kedrion Albumin (as Excipient) Product Offered
12.8.3 Kedrion Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Kedrion Main Business Overview
12.8.5 Kedrion Latest Developments
12.9 LFB Group
12.9.1 LFB Group Company Information
12.9.2 LFB Group Albumin (as Excipient) Product Offered
12.9.3 LFB Group Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 LFB Group Main Business Overview
12.9.5 LFB Group Latest Developments
12.10 Albumedix
12.10.1 Albumedix Company Information
12.10.2 Albumedix Albumin (as Excipient) Product Offered
12.10.3 Albumedix Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Albumedix Main Business Overview
12.10.5 Albumedix Latest Developments
12.11 Biotest
12.11.1 Biotest Company Information
12.11.2 Biotest Albumin (as Excipient) Product Offered
12.11.3 Biotest Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Biotest Main Business Overview
12.11.5 Biotest Latest Developments
12.12 Merck
12.12.1 Merck Company Information
12.12.2 Merck Albumin (as Excipient) Product Offered
12.12.3 Merck Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Merck Main Business Overview
12.12.5 Merck Latest Developments
12.13 Ventria (InVitria)
12.13.1 Ventria (InVitria) Company Information
12.13.2 Ventria (InVitria) Albumin (as Excipient) Product Offered
12.13.3 Ventria (InVitria) Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Ventria (InVitria) Main Business Overview
12.13.5 Ventria (InVitria) Latest Developments
12.14 HiMedia
12.14.1 HiMedia Company Information
12.14.2 HiMedia Albumin (as Excipient) Product Offered
12.14.3 HiMedia Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 HiMedia Main Business Overview
12.14.5 HiMedia Latest Developments

13 Research Findings and Conclusion

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ アルブミン(賦形剤)の世界市場2021-2026:ヒト血清アルブミン、組換えアルブミン(Global Albumin (as Excipient) Market Growth 2021-2026)]についてメールでお問い合わせはこちらでお願いします。